Astellas Pharma (Japan)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Japan), Japan, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
4.5K
Total Open
Publications
2.4K
Total
Citations
111K
Open Access
Percentage
53%
Total
Publications
4.5K
Total Open
Publications
2.4K
Total
Citations
111K
Breakdown
Publisher Open
26%
Both
22%
Other Platform Open
5%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 22%
479
Hybrid 42%
913
No Guarantees 36%
772
Other Platform Open
Domain 85%
1K
Institution 21%
257
Public 11%
141
Other Internet 6%
77
Preprint 4%
44
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1K |
Europe PMC | Domain | 708 |
Semantic Scholar | Public | 111 |
DOI | Other Internet | 64 |
Figshare | Public | 62 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 25 |
University College London - UCL Discovery | Institution | 22 |
Radboud University - Radboud Repository | Institution | 21 |
University of Bristol - Bristol Research | Institution | 20 |
Research Square | Preprint | 20 |